{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:36:23Z","timestamp":1793050583009,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of the Sunshine Coast","id":[{"id":"https:\/\/ror.org\/016gb9e15","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00213-026-07043-6","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T09:41:59Z","timestamp":1773654119000},"page":"2635-2647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Blood biomarker changes and relationships after low dose oral ketamine treatment for post-traumatic stress disorder (PTSD)"],"prefix":"10.1007","volume":"243","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3787-0993","authenticated-orcid":false,"given":"Bonnie L.","family":"Quigley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerald","family":"Orr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Kafka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Hajishafiee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana P.","family":"Bou\u00e7as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Wellington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Dutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Randall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Lagopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adem T.","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Hermens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"7043_CR1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-5","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Publishing, Inc., Arlington, VA, US"},{"key":"7043_CR2","doi-asserted-by":"crossref","unstructured":"Andrade C (2019) Oral ketamine for depression, 1: Pharmacologic considerations and clinical evidence. J Clin Psychiatry 80:19f12820","DOI":"10.4088\/JCP.19f12820"},{"key":"7043_CR3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2165\/00003495-200464040-00004","volume":"64","author":"GM Asnis","year":"2004","unstructured":"Asnis GM, Kohn SR, Henderson M, Brown NL (2004) SSRIs versus Non-SSRIs in Post-traumatic Stress Disorder. Drugs 64:383\u2013404","journal-title":"Drugs"},{"key":"7043_CR4","unstructured":"Australian Bureau of Statistics (2020) -21) National Study of Mental Health and Wellbeing"},{"key":"7043_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.neuropharm.2011.02.027","volume":"62","author":"DG Baker","year":"2012","unstructured":"Baker DG, Nievergelt CM, O\u2019Connor DT (2012) Biomarkers of PTSD: neuropeptides and immune signaling. Neuropharmacology 62:663\u2013673","journal-title":"Neuropharmacology"},{"key":"7043_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates D, M\u00e4chler M, Bolker B, Walker S (2015) Fitting Linear Mixed-Effects Models Using lme4. J Stat Softw 67:1\u201348","journal-title":"J Stat Softw"},{"key":"7043_CR7","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","volume":"11","author":"S Bathina","year":"2015","unstructured":"Bathina S, Das UN (2015) Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci 11:1164\u20131178","journal-title":"Arch Med Sci"},{"key":"7043_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/mpr.145","volume":"12","author":"P Bech","year":"2003","unstructured":"Bech P, Olsen LR, Kjoller M, Rasmussen NK (2003) Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale. Int J Methods Psychiatr Res 12:85\u201391","journal-title":"Int J Methods Psychiatr Res"},{"key":"7043_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J Roy Stat Soc: Ser B (Methodol) 57:289\u2013300","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"key":"7043_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1017\/S0033291715001981","volume":"46","author":"C Benjet","year":"2016","unstructured":"Benjet C, Bromet E, Karam EG, Kessler RC, McLaughlin KA, Ruscio AM, Shahly V, Stein DJ, Petukhova M, Hill E, Alonso J, Atwoli L, Bunting B, Bruffaerts R, Caldas-de-Almeida JM, de Girolamo G, Florescu S, Gureje O, Huang Y, Lepine JP, Kawakami N, Kovess-Masfety V, Medina-Mora ME, Navarro-Mateu F, Piazza M, Posada-Villa J, Scott KM, Shalev A, Slade T, ten Have M, Torres Y, Viana MC, Zarkov Z, Koenen KC (2016) The epidemiology of traumatic event exposure worldwide: results from the World Mental Health Survey Consortium. Psychol Med 46:327\u2013343","journal-title":"Psychol Med"},{"key":"7043_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.pnpbp.2008.12.004","volume":"33","author":"W Berger","year":"2009","unstructured":"Berger W, Mendlowicz MV, Marques-Portella C, Kinrys G, Fontenelle LF, Marmar CR, Figueira I (2009) Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry 33:169\u2013180","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"7043_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351\u2013354","journal-title":"Biol Psychiatry"},{"key":"7043_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/jts.22059","volume":"28","author":"CA Blevins","year":"2015","unstructured":"Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL (2015) The Posttraumatic Stress Disorder checklist for DSM-5 (PCL-5): Development and initial psychometric evaluation. J Trauma Stress 28:489\u2013498","journal-title":"J Trauma Stress"},{"key":"7043_CR14","doi-asserted-by":"crossref","unstructured":"Bouhaddou N, Mabrouk M, Atifi F, Bouyahya A, Zaid Y (2024) The link between BDNF and platelets in neurological disorders. Heliyon 10:e39278","DOI":"10.1016\/j.heliyon.2024.e39278"},{"key":"7043_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41398-021-01230-z","volume":"11","author":"AT Can","year":"2021","unstructured":"Can AT, Hermens DF, Dutton M, Gallay CC, Jensen E, Jones M, Scherman J, Beaudequin DA, Yang C, Schwenn PE, Lagopoulos J (2021) Low dose oral ketamine treatment in chronic suicidality: An open-label pilot study. Transl Psychiatry 11:101","journal-title":"Transl Psychiatry"},{"key":"7043_CR45","unstructured":"R Core Team (2024) R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.R-project.org\/"},{"key":"7043_CR16","first-page":"318","volume":"22","author":"LL Davis","year":"1997","unstructured":"Davis LL, Suris A, Lambert MT, Heimberg C, Petty F (1997) Post-traumatic stress disorder and serotonin: new directions for research and treatment. J Psychiatry Neurosci 22:318\u2013326","journal-title":"J Psychiatry Neurosci"},{"key":"7043_CR17","doi-asserted-by":"publisher","first-page":"104733","DOI":"10.1016\/j.neubiorev.2022.104733","volume":"139","author":"LP de Vries","year":"2022","unstructured":"de Vries LP, van de Weijer MP, Bartels M (2022) The human physiology of well-being: A systematic review on the association between neurotransmitters, hormones, inflammatory markers, the microbiome and well-being. Neurosci Biobehavioral Reviews 139:104733","journal-title":"Neurosci Biobehavioral Reviews"},{"key":"7043_CR19","doi-asserted-by":"publisher","first-page":"172837","DOI":"10.1016\/j.pbb.2019.172837","volume":"188","author":"S Deyama","year":"2020","unstructured":"Deyama S, Duman RS (2020) Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine. Pharmacol Biochem Behav 188:172837","journal-title":"Pharmacol Biochem Behav"},{"key":"7043_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.biopsych.2018.12.014","volume":"86","author":"S Deyama","year":"2019","unstructured":"Deyama S, Bang E, Kato T, Li XY, Duman RS (2019) Neurotrophic and antidepressant actions of brain-derived neurotrophic factor require vascular endothelial growth factor. Biol Psychiatry 86:143\u2013152","journal-title":"Biol Psychiatry"},{"key":"7043_CR20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/FPC.0b013e32835dc133","volume":"23","author":"KA Ellsworth","year":"2013","unstructured":"Ellsworth KA, Moon I, Eckloff BW, Fridley BL, Jenkins GD, Batzler A, Biernacka JM, Abo R, Brisbin A, Ji Y, Hebbring S, Wieben ED, Mrazek DA, Weinshilboum RM, Wang L (2013) FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder. Pharmacogenet Genomics 23:156\u2013166","journal-title":"Pharmacogenet Genomics"},{"key":"7043_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1192\/apt.bp.111.010041","volume":"19","author":"B Green","year":"2013","unstructured":"Green B (2013) Post-traumatic stress disorder: New directions in pharmacotherapy. Adv Psychiatr Treat 19:181\u2013190","journal-title":"Adv Psychiatr Treat"},{"key":"7043_CR22","doi-asserted-by":"publisher","first-page":"104590","DOI":"10.1016\/j.nbd.2019.104590","volume":"132","author":"W Guo","year":"2019","unstructured":"Guo W, Pang K, Chen Y, Wang S, Li H, Xu Y, Han F, Yao H, Liu H, Lopes-Rodrigues V, Sun D, Shao J, Shen J, Dou Y, Zhang W, You H, Wu W, Lu B (2019) TrkB agonistic antibodies superior to BDNF: Utility in treating motoneuron degeneration. Neurobiol Dis 132:104590","journal-title":"Neurobiol Dis"},{"key":"7043_CR23","unstructured":"Harrell F Jr (2025) Hmisc: Harrell Miscellaneous. R package version 5.2-2. https:\/\/github.com\/harrelfe\/hmisc"},{"key":"7043_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/pcn.12820","volume":"73","author":"H Hori","year":"2019","unstructured":"Hori H, Kim Y (2019) Inflammation and post-traumatic stress disorder. Psychiatry Clin Neurosci 73:143\u2013153","journal-title":"Psychiatry Clin Neurosci"},{"key":"7043_CR25","doi-asserted-by":"crossref","unstructured":"Johnston JN, Zarate CA, Kvarta MD (2024) Esketamine in depression: putative biomarkers from clinical research. European Archives of Psychiatry and Clinical Neuroscience","DOI":"10.1007\/s00406-024-01865-1"},{"key":"7043_CR26","doi-asserted-by":"publisher","first-page":"6983","DOI":"10.1038\/s41598-018-25529-y","volume":"8","author":"CF Kao","year":"2018","unstructured":"Kao CF, Liu YL, Yu YW, Yang AC, Lin E, Kuo PH, Tsai SJ (2018) Gene-based analysis of genes related to neurotrophic pathway suggests association of BDNF and VEGFA with antidepressant treatment-response in depressed patients. Sci Rep 8:6983","journal-title":"Sci Rep"},{"key":"7043_CR27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12888-024-05656-9","volume":"24","author":"JR Klaeth","year":"2024","unstructured":"Klaeth JR, Jensen AG, Auren TJB, Solem S (2024) 12-month follow-up of intensive outpatient treatment for PTSD combining prolonged exposure therapy, EMDR and physical activity. BMC Psychiatry 24:225","journal-title":"BMC Psychiatry"},{"key":"7043_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nn.3275","volume":"16","author":"T Klengel","year":"2013","unstructured":"Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM, Pace TW, Mercer KB, Mayberg HS, Bradley B, Nemeroff CB, Holsboer F, Heim CM, Ressler KJ, Rein T, Binder EB (2013) Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci 16:33\u201341","journal-title":"Nat Neurosci"},{"key":"7043_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/bdi.13412","volume":"26","author":"R Kumar","year":"2024","unstructured":"Kumar R, Nunez NA, Joshi N, Joseph B, Verde A, Seshadri A, Cuellar Barboza AB, Prokop LJ, Medeiros GC, Singh B (2024) Metabolomic biomarkers for (R, S)-ketamine and (S)-ketamine in treatment-resistant depression and healthy controls: A systematic review. Bipolar Disord 26:321\u2013330","journal-title":"Bipolar Disord"},{"key":"7043_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v082.i13","volume":"82","author":"A Kuznetsova","year":"2017","unstructured":"Kuznetsova A, Brockhoff PB, Christensen RHB (2017) lmerTest Package: Tests in Linear Mixed Effects Models. J Stat Softw 82:1\u201326","journal-title":"J Stat Softw"},{"key":"7043_CR31","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1038\/s41380-020-0750-4","volume":"26","author":"AJ Lesiak","year":"2021","unstructured":"Lesiak AJ, Coffey K, Cohen JH, Liang KJ, Chavkin C, Neumaier JF (2021) Sequencing the serotonergic neuron translatome reveals a new role for Fkbp5 in stress. Mol Psychiatry 26:4742\u20134753","journal-title":"Mol Psychiatry"},{"key":"7043_CR32","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1172\/JCI130363","volume":"130","author":"H Li","year":"2020","unstructured":"Li H, Su P, Lai TK, Jiang A, Liu J, Zhai D, Campbell CT, Lee FH, Yong W, Pasricha S, Li S, Wong AH, Ressler KJ, Liu F (2020) The glucocorticoid receptor-FKBP51 complex contributes to fear conditioning and posttraumatic stress disorder. J Clin Invest 130:877\u2013889","journal-title":"J Clin Invest"},{"key":"7043_CR33","first-page":"A4","volume":"34","author":"W L\u00f3pez-Ojeda","year":"2022","unstructured":"L\u00f3pez-Ojeda W, Hurley RA (2022) Extended Reality Technologies: Expanding Therapeutic Approaches for PTSD. J Neuropsychiatry Clin Neurosci 34:A4\u20135","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"7043_CR34","volume-title":"Manual for the Depression Anxiety Stress Scales","author":"SH Lovibond","year":"1995","unstructured":"Lovibond SH, Lovibond PF (1995) Manual for the Depression Anxiety Stress Scales, 2nd edn. Psychology Foundation, Sydney","edition":"2"},{"key":"7043_CR35","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1001\/archgenpsychiatry.2011.50","volume":"68","author":"D Mehta","year":"2011","unstructured":"Mehta D, Gonik M, Klengel T, Rex-Haffner M, Menke A, Rubel J, Mercer KB, Putz B, Bradley B, Holsboer F, Ressler KJ, Muller-Myhsok B, Binder EB (2011) Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies. Arch Gen Psychiatry 68:901\u2013910","journal-title":"Arch Gen Psychiatry"},{"key":"7043_CR36","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.biopsych.2015.01.005","volume":"78","author":"V Michopoulos","year":"2015","unstructured":"Michopoulos V, Norrholm SD, Jovanovic T (2015) Diagnostic biomarkers for posttraumatic stress disorder: Promising horizons from translational neuroscience research. Biol Psychiatry 78:344\u2013353","journal-title":"Biol Psychiatry"},{"key":"7043_CR37","doi-asserted-by":"publisher","first-page":"638377","DOI":"10.3389\/fpsyg.2021.638377","volume":"12","author":"O Muhorakeye","year":"2021","unstructured":"Muhorakeye O, Biracyaza E (2021) Exploring Barriers to Mental Health Services Utilization at Kabutare District Hospital of Rwanda: Perspectives From Patients. Front Psychol 12:638377","journal-title":"Front Psychol"},{"key":"7043_CR38","doi-asserted-by":"publisher","first-page":"102127","DOI":"10.1016\/j.eclinm.2023.102127","volume":"62","author":"S Nikolin","year":"2023","unstructured":"Nikolin S, Rodgers A, Schwaab A, Bahji A, Zarate C Jr., Vazquez G, Loo C (2023) Ketamine for the treatment of major depression: a systematic review and meta-analysis. EClinicalMedicine 62:102127","journal-title":"EClinicalMedicine"},{"key":"7043_CR39","doi-asserted-by":"crossref","unstructured":"Oglodek EA (2022) Changes in the serum concentration levels of serotonin, tryptophan and cortisol among stress-resilient and stress-susceptible individuals after experiencing traumatic stress. Int J Environ Res Public Health 19:16517","DOI":"10.3390\/ijerph192416517"},{"key":"7043_CR40","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S2215-0366(15)00309-0","volume":"2","author":"IC Passos","year":"2015","unstructured":"Passos IC, Vasconcelos-Moreno MP, Costa LG, Kunz M, Brietzke E, Quevedo J, Salum G, Magalhaes PV, Kapczinski F, Kauer-Sant\u2019Anna M (2015) Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. Lancet Psychiatry 2:1002\u20131012","journal-title":"Lancet Psychiatry"},{"key":"7043_CR41","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.bbapap.2018.03.006","volume":"1866","author":"B Pradhan","year":"2018","unstructured":"Pradhan B, Mitrev L, Moaddell R, Wainer IW (2018) d-Serine is a potential biomarker for clinical response in treatment of post-traumatic stress disorder using (R,S)-ketamine infusion and TIMBER psychotherapy: A pilot study. Biochim Biophys Acta Proteins Proteom 1866:831\u2013839","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"7043_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.euroneuro.2025.01.003","volume":"93","author":"BL Quigley","year":"2025","unstructured":"Quigley BL, Can AT, Dutton M, Gallay CC, Forsyth G, Jones M, Randall F, Wilson T, Lagopoulos J, Hermens DF (2025a) Low dose oral ketamine treatment on post-traumatic stress disorder (PTSD) (OKTOP): An open-label pilot study. Eur Neuropsychopharmacol 93:17\u201318","journal-title":"Eur Neuropsychopharmacol"},{"key":"7043_CR43","doi-asserted-by":"publisher","first-page":"100854","DOI":"10.1016\/j.jadr.2024.100854","volume":"19","author":"BL Quigley","year":"2025","unstructured":"Quigley BL, Wellington N, Dutton M, Bou\u00e7as AP, Forsyth G, Gallay CC, Hajishafiee M, Lagopoulos J, Can AT, Hermens DF (2025b) Mature brain-derived neurotrophic factor (BDNF) levels in serum correlate with symptom severity in post-traumatic stress disorder (PTSD). J Affect Disorders Rep 19:100854","journal-title":"J Affect Disorders Rep"},{"key":"7043_CR44","doi-asserted-by":"publisher","first-page":"7176","DOI":"10.1038\/s41598-025-91840-0","volume":"15","author":"BL Quigley","year":"2025","unstructured":"Quigley BL, Wellington N, Levenstein JM, Dutton M, Boucas AP, Forsyth G, Gallay CC, Haijishafiee M, Treacy C, Lagopoulos J, Andrews SC, Can AT, Hermens DF (2025c) Circulating biomarkers and neuroanatomical brain structures differ in older adults with and without post-traumatic stress disorder (PTSD). Sci Rep 15:7176","journal-title":"Sci Rep"},{"key":"7043_CR46","doi-asserted-by":"publisher","first-page":"204512532311541","DOI":"10.1177\/20451253231154125","volume":"13","author":"A Ragnhildstveit","year":"2023","unstructured":"Ragnhildstveit A, Roscoe J, Bass LC, Averill CL, Abdallah CG, Averill LA (2023) The potential of ketamine for posttraumatic stress disorder: a review of clinical evidence. Ther Adv Psychopharmacol 13:20451253231154125","journal-title":"Ther Adv Psychopharmacol"},{"key":"7043_CR47","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/da.22790","volume":"35","author":"ME Renna","year":"2018","unstructured":"Renna ME, O\u2019Toole MS, Spaeth PE, Lekander M, Mennin DS (2018) The association between anxiety, traumatic stress, and obsessive-compulsive disorders and chronic inflammation: A systematic review and meta-analysis. Depress Anxiety 35:1081\u20131094","journal-title":"Depress Anxiety"},{"key":"7043_CR48","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/00401706.1981.10486261","volume":"23","author":"JH Skillings","year":"1981","unstructured":"Skillings JH, Mack GA (1981) On the use of a Friedman-type statistic in balanced and unbalanced block designs. Technometrics 23:171\u2013177","journal-title":"Technometrics"},{"key":"7043_CR49","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.1523\/JNEUROSCI.19-14-05731.1999","volume":"19","author":"M Sondell","year":"1999","unstructured":"Sondell M, Lundborg G, Kanje M (1999) Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci 19:5731\u20135740","journal-title":"J Neurosci"},{"key":"7043_CR50","unstructured":"Srisuradetchai P (2015) Skillings.Mack: The Skillings\u2013Mack test statistic for block designs with missing observations (R package version 1.10), CRAN, Retrieved from https:\/\/cran.r-project.org\/package=Skillings.Mack"},{"key":"7043_CR51","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/17512433.2017.1260001","volume":"10","author":"E Thomas","year":"2017","unstructured":"Thomas E, Stein DJ (2017) Novel pharmacological treatment strategies for posttraumatic stress disorder. Expert Rev Clin Pharmacol 10:167\u2013177","journal-title":"Expert Rev Clin Pharmacol"},{"key":"7043_CR52","unstructured":"Warnes GR, Bolker BM, Bonebakker L, Gentleman R, Liaw W, Lumley T, Maechler M, Magnusson A, Moeller S, Schwartz ML, Venables BAB, Huber W, Liaw A, Gregory R, Warnes B, Bonebakker L, Liaw WHA, Lumley T, Maechler M, Magnusson A, Moeller S, Schwartz M, Venables BAB (2015) gplots: Various R Programming Tools for Plotting Data"},{"key":"7043_CR53","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1037\/pas0000486","volume":"30","author":"FW Weathers","year":"2018","unstructured":"Weathers FW, Bovin MJ, Lee DJ, Sloan DM, Schnurr PP, Kaloupek DG, Keane TM, Marx BP (2018) The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): Development and initial psychometric evaluation in military veterans. Psychol Assess 30:383\u2013395","journal-title":"Psychol Assess"},{"key":"7043_CR54","unstructured":"Wei SV (2024) R package \u2018corrplot\u2019: Visualization of a Correlation Matrix. (Version 0.95). https:\/\/github.com\/taiyun\/corrplot"},{"key":"7043_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"Ggplot2: Elegant graphics for data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H (2016) Ggplot2: Elegant graphics for data analysis, 2nd edn. Springer International Publishing, Cham, Switzerland","edition":"2"},{"key":"7043_CR56","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.biopsycho.2005.03.002","volume":"71","author":"E Williams","year":"2006","unstructured":"Williams E, Stewart-Knox B, Helander A, McConville C, Bradbury I, Rowland I (2006) Associations between whole-blood serotonin and subjective mood in healthy male volunteers. Biol Psychol 71:171\u2013174","journal-title":"Biol Psychol"},{"key":"7043_CR57","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jad.2020.02.044","volume":"268","author":"JJ Yang","year":"2020","unstructured":"Yang JJ, Jiang W (2020) Immune biomarkers alterations in post-traumatic stress disorder: A systematic review and meta-analysis. J Affect Disord 268:39\u201346","journal-title":"J Affect Disord"},{"key":"7043_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2024.02.045","volume":"173","author":"AK Zalta","year":"2024","unstructured":"Zalta AK, Voigt RM, Stevens SK, Held P, Raeisi S, Boley RA, Keshavarzian A, Pollack MH (2024) Brain derived neurotrophic factor and treatment outcomes among veterans attending an intensive treatment program for posttraumatic stress disorder. J Psychiatr Res 173:1\u20135","journal-title":"J Psychiatr Res"},{"key":"7043_CR59","doi-asserted-by":"publisher","first-page":"110954","DOI":"10.1016\/j.pnpbp.2024.110954","volume":"131","author":"Y Zou","year":"2024","unstructured":"Zou Y, Zhang Y, Tu M, Ye Y, Li M, Ran R, Zou Z (2024) Brain-derived neurotrophic factor levels across psychiatric disorders: A systemic review and network meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 131:110954","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07043-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-026-07043-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07043-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:02:52Z","timestamp":1793048572000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-026-07043-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["7043"],"URL":"https:\/\/doi.org\/10.1007\/s00213-026-07043-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research received approval from Metro North Health Human Research Ethics Committee (HREC) (Project ID: 42836; HREC\/18\/QPCH\/28), the University of the Sunshine Coast HREC (A181190) and was prospectively registered with the Clinical Trials Registry of Australia and New Zealand (ACTRN12618001965291, registered 05 December 2018).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they are unaware of any conflicts or competing financial interests in relation to the work described.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they are unaware of any conflicts or competing financial interests in relation to the work described.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent.","order":4,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have agreed to publish.","order":5,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}]}}